These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38244889)

  • 1. Molecular mechanism of rhinovirus escape from the Pyrazolo[3,4-d]pyrimidine capsid-binding inhibitor OBR-5-340 via mutations distant from the binding pocket: Derivatives that brake resistance.
    Richter M; Döring K; Blaas D; Riabova O; Khrenova M; Kazakova E; Egorova A; Makarov V; Schmidtke M
    Antiviral Res; 2024 Feb; 222():105810. PubMed ID: 38244889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
    Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical Evolution of Rhinovirus Identifies Capsid-Destabilizing Mutations Driving Low-pH-Independent Genome Uncoating.
    Murer L; Petkidis A; Vallet T; Vignuzzi M; Greber UF
    J Virol; 2022 Jan; 96(2):e0106021. PubMed ID: 34705560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.
    Basta HA; Ashraf S; Sgro JY; Bochkov YA; Gern JE; Palmenberg AC
    Virology; 2014 Jan; 448():82-90. PubMed ID: 24314639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
    Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
    J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
    Egorova A; Ekins S; Schmidtke M; Makarov V
    Eur J Med Chem; 2019 Sep; 178():606-622. PubMed ID: 31226653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of a specific capsid binder resistance caused by mutations outside the binding pocket.
    Braun H; Kirchmair J; Williamson MJ; Makarov VA; Riabova OB; Glen RC; Sauerbrei A; Schmidtke M
    Antiviral Res; 2015 Nov; 123():138-45. PubMed ID: 26391975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.
    Abdelnabi R; Geraets JA; Ma Y; Mirabelli C; Flatt JW; Domanska A; Delang L; Jochmans D; Kumar TA; Jayaprakash V; Sinha BN; Leyssen P; Butcher SJ; Neyts J
    PLoS Biol; 2019 Jun; 17(6):e3000281. PubMed ID: 31185007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ICAM-1 induced rearrangements of capsid and genome prime rhinovirus 14 for activation and uncoating.
    Hrebík D; Füzik T; Gondová M; Šmerdová L; Adamopoulos A; Šedo O; Zdráhal Z; Plevka P
    Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33947819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility of coxsackievirus B3 laboratory strains and clinical isolates to the capsid function inhibitor pleconaril: antiviral studies with virus chimeras demonstrate the crucial role of amino acid 1092 in treatment.
    Schmidtke M; Hammerschmidt E; Schüler S; Zell R; Birch-Hirschfeld E; Makarov VA; Riabova OB; Wutzler P
    J Antimicrob Chemother; 2005 Oct; 56(4):648-56. PubMed ID: 16150864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
    Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
    Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinovirus Inhibitors: Including a New Target, the Viral RNA.
    Real-Hohn A; Blaas D
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel benzonitrile analogue inhibits rhinovirus replication.
    Lacroix C; Querol-Audí J; Roche M; Franco D; Froeyen M; Guerra P; Terme T; Vanelle P; Verdaguer N; Neyts J; Leyssen P
    J Antimicrob Chemother; 2014 Oct; 69(10):2723-32. PubMed ID: 24948704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human rhinovirus 3 at 3.0 A resolution.
    Zhao R; Pevear DC; Kremer MJ; Giranda VL; Kofron JA; Kuhn RJ; Rossmann MG
    Structure; 1996 Oct; 4(10):1205-20. PubMed ID: 8939746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the genetic basis for natural phenotypic resistance of human rhinoviruses to pleconaril.
    Ledford RM; Collett MS; Pevear DC
    Antiviral Res; 2005 Dec; 68(3):135-8. PubMed ID: 16199099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyrazolopyrimidines: Potent Inhibitors Targeting the Capsid of Rhino- and Enteroviruses.
    Makarov VA; Braun H; Richter M; Riabova OB; Kirchmair J; Kazakova ES; Seidel N; Wutzler P; Schmidtke M
    ChemMedChem; 2015 Oct; 10(10):1629-34. PubMed ID: 26260222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Based Drug Design of Potent Pyrazole Derivatives against Rhinovirus Replication.
    Da Costa L; Scheers E; Coluccia A; Casulli A; Roche M; Di Giorgio C; Neyts J; Terme T; Cirilli R; La Regina G; Silvestri R; Mirabelli C; Vanelle P
    J Med Chem; 2018 Sep; 61(18):8402-8416. PubMed ID: 30153009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Epitopes on Rhinovirus 89 Capsid Proteins Capable of Inducing Neutralizing Antibodies.
    Niespodziana K; Cabauatan CR; Pazderova P; Vacal PC; Wortmann J; Keller W; Errhalt P; Valenta R
    Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociation of an antiviral compound from the internal pocket of human rhinovirus 14 capsid.
    Li Y; Zhou Z; Post CB
    Proc Natl Acad Sci U S A; 2005 May; 102(21):7529-34. PubMed ID: 15899980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New class of early-stage enterovirus inhibitors with a novel mechanism of action.
    Ma Y; Abdelnabi R; Delang L; Froeyen M; Luyten W; Neyts J; Mirabelli C
    Antiviral Res; 2017 Nov; 147():67-74. PubMed ID: 28993161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.